OralParenteralDosed ingredientTherapeutic flag Cosmetic cross-reference

Calcium Acetate

CAS 62-54-4

Calcium Acetate (CAS 62-54-4) is a Phase 4 pharmaceutical compound with 0 bioactivity targets and 426 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
426
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Calcium Acetate
CAS Number
62-54-4
UNII
Y882YXF34X
InChIKey
VSGNNIFQASZAOI-UHFFFAOYSA-L
ChEMBL ID
CHEMBL1200800
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientoralparenteraltherapeutic flag
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200800 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Nephrogenic systemic fibrosis 147 515.117 10067467
Peritonitis bacterial 101 290.777 10062070
Skin induration 74 242.817 10051837
Skin hypertrophy 68 207.679 10040867
Skin tightness 60 172.002 10050637
Calciphylaxis 49 150.177 10051714
Skin fibrosis 37 132.872 10050207
Joint contracture 41 124.88 10023201
Peritonitis 78 122.58 10034674
Chronic kidney disease 120 107.735 10064848
Hypervolaemia 79 100.967 10020919
Fibrosis 39 90.665 10016642
Dialysis 54 88.965 10061105
Blood parathyroid hormone increased 31 77.475 10005703
Scar 48 76.758 10039580
Haemodialysis 47 76.478 10018875
Peritoneal dialysis complication 26 74.805 10067594
Skin hyperpigmentation 36 73.144 10040865
Joint range of motion decreased 61 70.266 10048706
Extremity contracture 23 69.882 10050732
End stage renal disease 46 65.98 10077512
Aplasia pure red cell 34 63.456 10002965
Drug ineffective 137 59.319 10013709
Hypercalcaemia 55 54.578 10020583
Anhedonia 37 54.322 10002511
Renal failure 139 54.19 10038435
Off label use 103 51.04 10053762
Emotional distress 53 50.483 10049119
Azotaemia 28 49.414 10003885
Peau d'orange 12 48.595 10049752
Haemoglobin decreased 136 47.714 10018884
Skin discolouration 54 44.298 10040829
Blood phosphorus increased 27 43.104 10050196
Hypocalcaemia 54 42.889 10020947
Cardiac arrest 105 42.361 10007515
Respiratory tract infection bacterial 16 42.062 10060693
Treatment failure 3 41.275 10066901
Therapeutic response decreased 69 40.635 10043414
Drug intolerance 14 39.318 10061822
Anti-erythropoietin antibody positive 13 38.413 10048681
Fungal peritonitis 13 37.662 10061138
Hypotension 194 37.463 10021097
Cardiac failure congestive 92 35.258 10007559
Product use issue 9 35.087 10076309
Haemodialysis complication 9 34.95 10070476
Anaemia 200 34.55 10002034
Kidney transplant rejection 24 33.693 10023439
Contraindicated product administered 6 33.573 10078504
Milk-alkali syndrome 12 32.445 10027635
Oedema peripheral 130 31.273 10030124

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
calcium acetate 214342 SU MTHSPL
CALCIUM ACETATE 214342 SU MTHSPL
calcium acetate 214342 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Calcium Acetate used for in pharmaceutical contexts?

Calcium Acetate (CAS 62-54-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Calcium Acetate?

Calcium Acetate has 426 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Nephrogenic systemic fibrosis, Peritonitis bacterial, Skin induration, Skin hypertrophy, Skin tightness. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Calcium Acetate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Calcium Acetate with EU status "permitted".

What clinical phase is Calcium Acetate in?

Calcium Acetate is rendered with ChEMBL max phase 4 (approved).